Man, Daughter, and Grandson and Person Typing on Computer


The Center for Safe Internet Pharmacies’ blog profiles efforts to address the growing problem of consumer access to illegitimate pharmaceutical products on the Internet from the perspective of CSIP staff and board members and partners. It is updated on a a regular basis with new information and breaking news stories so be sure to check back often.


Supporting Individuals with Substance Use Disorders During COVID-19

Coronavirus disease 2019 (COVID-19) has forever changed the American landscape. From the economy to the health care system to family/community dynamics, we wonder when “normal” will return and what that will look like. We also see that the COVID-19 crisis has only further spotlighted the health disparities and challenges facing our most at-risk individuals and families. Amid trying to socially distance and stay safe, we cannot forget those who are facing this pandemic while also facing chronic diseases – including substance use disorders. Read More


Opioid Policy and News Updates: April 2020

Woman typing at keyboard

Each week the Collaborative for Effective Prescription Opioid Policies (CEPOP) produce an opioid policy and news update. This report compiles resources related to federal and state legislative and other news on the opioid epidemic. In this blog post, we share a few highlights from their latest edition and thank CEPOP staff for their hard work. Read More


COVID-19 and Opioids: Overcoming Challenges to Protect Those In Need

Female medicine doctor working on table with consulting patient, wearing mask to prevent viruses

As we face an international public health crisis not experienced in the lifetime of even some of our oldest citizens, we, at CSIP, are truly grateful to all frontline health care workers who are supporting families around the country. While the acute concerns of “Novel Coronavirus Disease 2019” (COVID-19) plague cities around the US, there is also the underlying concern for those facing more long-term health issues – including those in opioid addiction treatment and those in need of regulated opioids for medical issues. Read More